Epitope Tags beside the N-terminal cytoplasmic tail of human BST-2 alter its intracellular trafficking and HIV-1 restriction

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Lv, Mingyu ^a   Wang, Jiawen ^a,b   Zhang, Jingyao ^a   Zhang, Biao ^a   Wang, Xiaodan ^a   Zhu, Yingzi ^a   Zuo, Tao ^a   Liu, Donglai ^a   Li, Xiaojun ^a   Wu, Jiaxin ^a   Zhang, Haihong ^a   Yu, Bin ^a   Wu, Hui ^a   Zhao, Xinghong ^a   Kong, Wei ^a   Yu, Xianghui ^a  

^a JILIN UNIVERSITY   (China)

^b CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BST 2 PROTEIN; EPITOPE; MEMBRANE PROTEIN; PROTEIN; UNCLASSIFIED DRUG; BST2 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; SIGNAL PEPTIDE;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR TRANSPORT; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; HEK293 CELL LINE; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; CERCOPITHECUS AETHIOPS; COS CELLS; EPITOPES; GPI-LINKED PROTEINS; HEK293 CELLS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT;

EID: 84908577868     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111422     Document Type: Article

References (58)

1. Goff SP (2007) Host factors exploited by retroviruses. Nat Rev Microbiol 5: 253-263.
2. Freed EO (2004) HIV-1 and the host cell: an intimate association. Trends Microbiol 12: 170-177.
3. Sheehy AM, Gaddis NC, Choi J.D., Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650.
4. Neil SJ, Zang T, Bieniasz PD (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430.
5. Van Damme N, Goff D, Katsura C., Jorgenson RL, Mitchell R, et al. (2008) The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3: 245-252.
6. Neil SJ, Sandrin V, Sundquist W.I., Bieniasz PD (2007) An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2: 193-203.
7. Huthoff H, Towers GJ (2008) Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha. Trends Microbiol 16: 612-619.
8. Stremlau M, Perron M, Lee M., Li Y, Song B, et al. (2006) Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A 103: 5514-5519.
9. Stremlau M, Owens CM, Perron M.J., Kiessling M., Autissier P, et al. (2004) The cytoplasmic body component TRIM5 alpha restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
10. Laguette N, Sobhian B, Casartelli N., Ringeard M, Chable-Bessia C, et al. (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654-657.
11. Goldstone DC, Ennis-Adeniran V, Hedden J.J., Groom HC, Rice GI, et al. (2011) HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480: 379-382.
12. Yu X, Yu Y, Liu B., Luo K, Kong W, et al. (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302: 1056-1060.
13. Sheehy AM, Gaddis NC, Malim MH (2003) The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9: 1404-1407.
14. Hrecka K, Hao C, Gierszewska M., Swanson SK, Kesik-Brodacka M, et al. (2011) Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474: 658-661.
15. Ahn J, Hao C, Yan J., DeLucia M, Mehrens J, et al. (2012) HIV/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1. J Biol Chem 287: 12550-12558.
16. Jouvenet N, Neil SJ, Zhadina M, Zang T., Kratovac Z, et al. (2009) Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 83: 1837-1844.
17. Sakuma T, Noda T, Urata S., Kawaoka Y, Yasuda J (2009) Inhibition of Lassa and Marburg virus production by tetherin. J Virol 83: 2382-2385.
18. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P (2009) Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci U S A 106: 2886-2891.
19. Kupzig S, Korolchuk V, Rollason R., Sugden A, Wilde A, et al. (2003) Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4: 694-709.
20. Perez-Caballero D, Zang T, Ebrahimi A., McNatt MW, Gregory DA, et al. (2009) Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139: 499-511.
21. Arnaud F, Black SG, Murphy L, Griffiths D.J., Neil SJ, et al. (2010) Interplay between ovine bone marrow stromal cell antigen 2/tetherin and endogenous retroviruses. J Virol 84: 4415-4425.
22. Mattiuzzo G, Ivol S, Takeuchi Y (2010) Regulation of porcine endogenous retrovirus release by porcine and human tetherins. J Virol 84: 2618-2622.
23. Fukuma A, Abe M, Morikawa Y., Miyazawa T, Yasuda J (2011) Cloning and characterization of the antiviral activity of feline Tetherin/BST-2. PLoS One 6: e18247.
24. Matsuda A, Suzuki Y, Honda G., Muramatsu S, Matsuzaki O, et al. (2003) Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22: 3307-3318.
25. Galao RP, Le Tortorec A, Pickering S, Kueck T., Neil SJ (2012) Innate sensing of HIV-1 assembly by Tetherin induces NFkappaB-dependent proinflammatory responses. Cell Host Microbe 12: 633-644.
26. Cocka LJ, Bates P (2012) Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities. PLoS Pathog 8: e1002931.
27. Tokarev A, Suarez M, Kwan W., Fitzpatrick K, Singh R, et al. (2013) Stimulation of NF-kappaB activity by the HIV restriction factor BST2. J Virol 87: 2046-2057.
28. Strebel K, Klimkait T, Martin MA (1988) A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241: 1221-1223.
29. Huet T, Cheynier R, Meyerhans A., Roelants G, Wain-Hobson S (1990) Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature 345: 356-359.
30. Cohen EA, Terwilliger EF, Sodroski J.G., Haseltine WA (1988) Identification of a protein encoded by the vpu gene of HIV-1. Nature 334: 532-534.
31. Maldarelli F, Chen MY, Willey R.L., Strebel K (1993) Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J Virol 67: 5056-5061.
32. Iwabu Y, Fujita H, Kinomoto M., Kaneko K, Ishizaka Y, et al. (2009) HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J Biol Chem 284: 35060-35072.
33. Dube M, Roy BB, Guiot-Guillain P, Mercier J., Binette J, et al. (2009) Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J Virol 83: 4574-4590.
34. Douglas JL, Viswanathan K, McCarroll M.N., Gustin JK, Fruh K, et al. (2009) Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J Virol 83: 7931-7947.
35. Mangeat B, Gers-Huber G, Lehmann M., Zufferey M, Luban J, et al. (2009) HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog 5: e1000574.
36. Gupta RK, Mlcochova P, Pelchen-Matthews A, Petit S.J., Mattiuzzo G., et al. (2009) Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc Natl Acad Sci U S A 106: 20889-20894.
37. Jia B, Serra-Moreno R, Neidermyer W., Rahmberg A, Mackey J, et al. (2009) Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog 5: e1000429.
38. Le Tortorec A, Neil SJ (2009) Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J Virol 83: 11966-11978.
39. Zhang F, Wilson SJ, Landford W.C., Virgen B., Gregory D, et al. (2009) Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6: 54-67.
40. Celestino M, Calistri A, Del Vecchio C, Salata C, Chiuppesi F., et al. (2012) Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein. J Virol 86: 6688-6700.
41. Tokarev AA, Munguia J, Guatelli JC (2011) Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu. J Virol 85: 51-63.
42. Gustin JK, Douglas JL, Bai Y, Moses AV (2012) Ubiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain. J Biol Chem 287: 14837-14850.
43. Miyakawa K, Ryo A, Murakami T., Ohba K, Yamaoka S, et al. (2009) BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction. PLoS Pathog 5: e1000700.
44. Sakuma T, Sakurai A, Yasuda J (2009) Dimerization of tetherin is not essential for its antiviral activity against Lassa and Marburg viruses. PLoS One 4: e6934.
45. Lv M, Wang J, Wang X., Zuo T, Zhu Y, et al. (2011) Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity. PLoS One 6: e20890.
46. Wang J, Zhang W, Lv M., Zuo T, Kong W, et al. (2011) Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins. J Virol 85: 12482-12491.
47. Lv M, Wang J, Zhu Y., Wang X, Zuo T, et al. (2013) Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin. FEBS Lett 587: 37-43.
48. Lim ES, Malik HS, Emerman M (2010) Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses. J Virol 84: 7124-7134.
49. Yang H, Wang J, Jia X., McNatt MW, Zang T, et al. (2010) Structural insight into the mechanisms of enveloped virus tethering by tetherin. Proc Natl Acad Sci U S A 107: 18428-18432.
50. Swiecki M, Scheaffer SM, Allaire M, Fremont D.H., Colonna M., et al. (2011) Structural and biophysical analysis of BST-2/tetherin ectodomains reveals an evolutionary conserved design to inhibit virus release. J Biol Chem 286: 2987-2997.
51. Schubert HL, Zhai Q, Sandrin V., Eckert DM, Garcia-Maya M, et al. (2010) Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations. Proc Natl Acad Sci U S A 107: 17951-17956.
52. Hinz A, Miguet N, Natrajan G., Usami Y, Yamanaka H, et al. (2010) Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain. Cell Host Microbe 7: 314-323.
53. Lv M, Zhu Y, Wang J., Zhang H, Wang X, et al. (2013) Purification of eukaryotic tetherin/Vpu proteins and detection of their interaction by ELISA. Protein Expr Purif 91: 112-118.
54. Masuyama N, Kuronita T, Tanaka R., Muto T, Hirota Y, et al. (2009) HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin. J Biol Chem 284: 15927-15941.
55. Tirabassi RS, Enquist LW (1999) Mutation of the YXXL endocytosis motif in the cytoplasmic tail of pseudorabies virus gE. J Virol 73: 2717-2728.
56. Ohno H, Aguilar RC, Fournier M.C., Hennecke S., Cosson P, et al. (1997) Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family. Virology 238: 305-315.
57. Hauser H, Lopez LA, Yang S.J., Oldenburg JE, Exline CM, et al. (2011) HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 8: 85.
58. Billcliff PG, Gorleku OA, Chamberlain L.H., Banting G (2013) The cytosolic N-terminus of CD317/tetherin is a membrane microdomain exclusion motif. Biol Open 2: 1253-1263.